1. Matrin-3 plays an important role in cell cycle and apoptosis for survival in malignant melanoma
- Author
-
Takayuki Ishibashi, Kanako Kita, Toshihiro Kimura, Jun Aoi, Ikko Kajihara, Katsunari Makino, Hironobu Ihn, Haruka Kuriyama, Seiji Okada, Satoru Mizuhashi, Hisashi Kanemaru, Satoshi Fukushima, Azusa Miyashita, and Etsuko Okada
- Subjects
Adult ,Male ,0301 basic medicine ,Skin Neoplasms ,Adolescent ,Cell Survival ,Biopsy ,Antineoplastic Agents ,Apoptosis ,Dermatology ,Biology ,Fibroblast growth factor ,Biochemistry ,Mice ,Young Adult ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Nuclear Matrix-Associated Proteins ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Child ,Melanoma ,Nevus ,Molecular Biology ,Aged ,Cell Proliferation ,Aged, 80 and over ,Gene knockdown ,Cell Cycle ,RNA-Binding Proteins ,Neural crest ,Middle Aged ,Cell cycle ,medicine.disease ,G1 Phase Cell Cycle Checkpoints ,Xenograft Model Antitumor Assays ,Neural stem cell ,Gene Expression Regulation, Neoplastic ,030104 developmental biology ,Cell culture ,Child, Preschool ,Gene Knockdown Techniques ,Cancer research ,Female ,Stem cell - Abstract
Background A previous study revealed that matrin-3 is an essential component in maintaining fibroblast growth factor 2 (FGF2)-mediated undifferentiation of neural stem cells (NSCs) using a proteomics approach. Malignant melanoma (MM) arises from melanocytes that originate from neural crest stem cells during development. Additionally, it has been reported that the expression of FGF2 is positively correlated with the progression of MM. Objective We expected that matrin-3, as a downstream component of FGF2, might be associated with the aggressiveness or differentiation of MM. Methods Matrin-3 expression was measured in human melanoma patient tissues and human MM cell lines. We analyzed the effect of matrin-3 siRNA on the proliferation of human MM cell lines and focused on cell cycle progression and apoptosis. We carried out in vivo xenograft tumor experiments by implanting A375 cells transfected with matrin-3 shRNA. Results Matrin-3 was highly expressed in MM, and matrin-3 knockdown inhibited the proliferation of melanoma cellsin vivo and in vitro. Furthermore, we found that matrin-3 knockdown led to an accumulation of cells in the G1 phase and an increase in apoptotic cell number. Conclusion Our results suggest that matrin-3 could be a new therapeutic target for the treatment of MM.
- Published
- 2020